Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses
Jacquelyn Bainbridge, PharmD; Rebecca Barnhart, PharmD; Ryan Fuller, PharmD; Van T. Hellerslia, PharmD; Julie Kidd, PharmD; Steven Merrill, PharmD; Emily…
Large study finds greater risk of Infection with progressive forms than RRMS
by Patricia Valerio, PhD | October 20, 2022 People with progressive forms of multiple sclerosis (MS) are nearly four times more likely…
Stuart Schlossman
FDA Backs Further Development of Blood Biomarker, Neurofilament Light, for Clinical Trials in Progressive MS – International Progressive MS Alliance
A major milestone in the goal of increasing the number and speed of clinical trials in progressive multiple sclerosis was…
Stuart Schlossman
Managing PPMS and Your Career
Having primary progressive multiple sclerosis (PPMS) can warrant adjustments to various aspects of your life, including your job. In severe…
Stuart Schlossman
United States Progressive Relapsing Multiple Sclerosis Treatment Market to 2025: New Tech Developments, Advancements, Key Players, Strategies to Boost Industry Growth
Article is more scientific than for the everyday person. However, I am posting this to show, that there are many…
Stuart Schlossman
Information concerning Primary progressive MS (PPMS)
PPMS is characterized by worsening neurologic function (accumulation of disability) from the onset of symptoms, without early relapses or remissions. PPMS can be…
Stuart Schlossman
Clomipramine, an Antidepressant, Shows Potential in Treating Progressive MS in Early Study
December 29, 2017 Clomipramine, an approved antidepressant, shows potential in treating people with progressive multiple sclerosis (MS) — a disease…
Stuart Schlossman
Primary Progressive MS: Myths vs. Facts
Primary progressive multiple sclerosis (PPMS) is a complex disease that varies between individuals. In other words, not everyone will have…
Stuart Schlossman
Medical Decision-Making in Progressive MS
…
Stuart Schlossman
Ocrevus Phase 3 Trial Will Explore How Treatment Works by Viewing Changes in Spinal Fluid
…
Stuart Schlossman
